Get started

VEEV

Veeva Announces Fiscal 2025 First Quarter Results Shares drop 8%Veeva Systems Inc., ( NYSE:VEEV ) a leading provider of cloud solutions for the global life sciences industry, announced its fiscal 2025 first quarter results, which showed a 24% increase in revenues and a 29% increase in subscription services revenues. Operating income increased by 152% YoY to $155.2 million, while non-GAAP operating income rose by 66% YoY to $260.9 million. Net income also increased by 23% YoY to $161.7 million, while non-GAAP net income rose by 67% YoY to $247.0 million. The company's interim CFO and Board Director, Tim Cabral, expressed confidence in the company's performance, stating that they are investing for durable growth and are committed to customer success and product excellence. The company also reported significant wins in clinical, quality, regulatory, and safety, including three top 20 biopharma wins for multiple Development Cloud applications. Veeva Vault ( NYSE:VEEV ) Basics applications are now available, preconfigured with industry standard processes and managed by Veeva with no implementation cost, allowing emerging biotechs to start with Development Cloud earlier in their lifecycle and graduate easily to full Development Cloud as they grow. The Vault CRM Suite progress continues, with the full availability of Vault CRM for all new customers in April, and 13 CRM wins in the quarter. Veeva ( NYSE:VEEV ) added 21 new brands for Compass Patient in the first quarter, including its first seven-figure enterprise-wide win with a top 50 biopharma. The company also signed the first Compass Prescriber and Compass National customers, providing more complete and accurate data than legacy alternatives. Veeva Link also continued to progress well, crossing the 100-customer mark, as the industry enhances engagement through real-time intelligence. Financial outlook for Veeva ( NYSE:VEEV ) is provided for the fiscal second quarter ending July 31, 2024, with total revenues between $666 and $669 million, non-GAAP operating income between $265 and $267 million, and non-GAAP fully diluted net income per share between $1.53 and $1.54. Technically, Veeva Vault ( NYSE:VEEV ) stock is currently oversold with a Relative Strength Index (RSI) of 17.97. The daily price chart shows a "Bearish Harami" candle stick pattern accentuating the bearish campaign.
NYSE:VEEVShort
by DEXWireNews
IOT repeating a move from VEEV in 2017 Very BullishSince I have been using chatGPT, I have taken a very bullish approach to all things ai. This stock is one of the leading in its sector. While charting it I noticed it had the same Chart Pattern as VEEV in 2017. Which went from 17 - 50 in 8 months. So far this stock has spent 4 months under institutional control since it hit its low and started Accumulation. Its low is around $8.50 and looks like its following this pattern almost perfectly.... there are some efficiency differences but somehow gets all the moves still in there. Ill post the Chart here for you to see. by iCantw84it 03.30.23
NYSE:IOTLong
by iCantw84it
5
Veeva SystemsThis is a daily chart of Veeva Systems (VEEV), a healthcare technology company that provides cloud solutions for the global life sciences industry. When the company reported its earnings on August 31st the stock price subsequently gapped down, as shown in the chart above. From a probability standpoint, this gap is likely to be filled for the reasons below. 1. The gap is a monthly candle gap and these usually close. Unfilled gaps on the monthly charts are generally quite rare, especially for assets that have never left a monthly gap before. As shown in the chart below, VEEV has never left a gap on its monthly chart before. 2. The gap is below the lower regression channel line. A regression channel is used to measure how far above or below an asset is trading from its mean. Since price generally tends to mean revert, it's highly unlikely that a gap below the lower channel line, (which in this case represents two standard deviations below the mean), will never be filled. It's more likely that the gap will not only be filled, but will be filled quite rapidly. The assumption I make in using this regression channel is that it is statistically valid and data are normally distributed. If true, then there's only a small probability that VEEV's monthly candle will close the month so far below the lower line of the regression channel. Therefore, it's likely that price will be drawn back up to the mean, and thus the gap will be filled. Here's a close up view: 3. Price gapped below an important Fibonacci level that has been holding, and likely will continue to hold, as support. See the chart below. Here are some close up views: At a minimum, price will very likely push back into the 180s. The quarterly chart shows long lower wicks at this Fibonacci level, indicating that it is holding as support. With further momentum to the downside waning as shown by the Stochastic RSI, there's little reason to believe this Fibonacci level will fail this time. The lower wicks on the quarterly candles are also bouncing off of the exponential moving average (EMA) ribbon, which usually acts as support when price descends to it from above. Strategy With this said, I noticed that someone is already sweeping the call options. They swept hundreds of out-of-the-money (OTM) call options expiring on 9/16 with a $180 strike. Clearly, this buyer believes that VEEV's price is poised to quickly return at least to the Fibonacci support level of $180.97. If you don't know what an options sweep is, it simply refers to an instance in which options are purchased right at the ask price. In most cases, buyers place a limit buy at the mid point of the bid-ask spread or at a lower target price. Market participants usually only buy at the ask price if they're in a rush to buy and/or if they have a high confidence about a certain market move and want to guarantee their entry while also not tipping the market off about their anticipated market move. Sweeps can also refer to when a large buyer wants to obfuscate their entry by splitting their large order into a lot of smaller parts to sweep the entire order book without tipping off the market as they would have if they placed a single large limit order. Understanding sweeps can help you understand what smart money is doing. It's very rare that retail traders sweep the order book because it's very expensive, and for a smaller portfolio (less than a million) it can be extremely risky. Therefore, smart money is usually the market participant who sweeps the order book. Personally, I find this call sweep to be risky (assuming that it's not part of some kind of a hedge) since although we have a high confidence that the gap may close, we don't know within what time frame it will do so. Rather than sweeping a call option with a strike price of $180 that expires on 9/16 a safer though less lucrative trade would be to sell a cash-secured put with a strike price of $180 and which expires on 9/16. Doing this gives you much higher odds of winning but is profit limited. If the price goes to $180 or higher at expiration, you win the full premium since the put you sold will not be exercised. If the price is below $180 but above the breakeven price at expiration, or if the price is below even your breakeven price, then you may be forced to buy shares of VEEV at $180, but you can simply hold those shares until the gap closes (or longer if you think price is going higher). Therefore in this case you still do not lose money, and still make the premium as profit. The only plausible scenario whereby you would lose money would be if VEEV's price continued to plummet and never recovers. Although this would be incredibly unlikely, it is still possible. You can nonetheless still hedge against even this risk by using a put spread to limit loss potential to a ratio that meets your risk management strategy. Therefore you can safely take a very high probability trade while managing risks well. Successful trading is mostly determined by how well you manage risks. Finally, since options are leveraged, one should always try to time their entry as perfectly as possible by using shorter timeframe (hourly or 4-hour) charts, especially if the option's expiration is close. For example, you can see that the 4 hour chart for VEEV is showing momentum building back to the upside. This is what you want to see if you're going to sell a put option strategy that expires on 9/16. These are just my thoughts and they are definitely not meant to be trading advice. As always, anything can happen. September can often be a volatile month and is prone to declines. Options trading is risky and can result in complete loss. Trade at your own risk. If you would like me to post more strategies like this on here leave a boost or a comment below so I can gauge interest. Thank you. If you're new to trading and don't understand the options trading language that I used above, I would recommend Project Finance to learn about options. I learned a ton about options trading from this channel and the content is always high-quality: www.youtube.com If you want to learn more about the basics of trading, you can see my post linked below for 10 rules for successful trading.
NYSE:VEEV
by SpyMasterTrades
22
What a stage 3 top looks like - Stock short idea (VEEV)Some basic rules I have for shorting: Must be below all key moving averages on the daily time frame - 10d/20d/50d/200dma Broke down from a stage 3 top or in a stage 4 decline Basing period / consolidation - the longer the better Low relative strength rating (not RSI - people mistake the two) Group/industry must be weak on a relative basis Ideally earnings and margins are declining The do-nots: I do not short stocks because they are "extended" Never short stocks in stage 1 bases or stage 2 uptrends, nor stage 3 tops until a breakdown is confirmed Do not short biotech, small caps/low market capitalization - I want to short something that's generally too big to get acquired Here's a view of VEEV on the daily time frame:
NYSE:VEEVShort
by Lanmar
68
VEEV, Long to 358 USD. An easy long setup !VEEV is on the way to 358 USD ? Surely it is possible ! VEEV may have started the new up going wave ( labeled wave 5 ) bouncing back from 50 % retracement of the last rally ( labled wave 3) and after completion of an abc form of correction. If true it will go up to complete the up going Elliott wave cycle around 358 USD. Target may need update later based on internal structure of up coming wave 5. Stochastic indicator has recently made a bullish reversal in oversold zone in daily time frame. A small bullish divergence can be noticed on indicator as well. Taking out 307.05 minor high will strengthen this analysis and confirmation will be taking out labeled wave (b). Besides all these bullish signs, market may choose completely different path for VEEV. Therefore we set our stop loss carefully if we decide to open a long position. Trade set up: Position : Long Entry : Current prices or you can wait for mentioned minor high to be taken out. Stop Loss : 293.2 Target : 358 Reward to Risk : around 8 ! if you enter at current prices. Good luck my friends
NYSE:VEEVLong
by SaeedSajedi
2
Veeva Systems: One of my favourite stocks right nowI love it when fundamentals and technicals line up together. I am in general very bullish towards cloud-software companies, thats the future, especially when they have a footing in the pharma industry like veeva. This is a huge market and growing strongly year by year. The chart is a textbook bull flag. I am expecting a move into 80$ over the coming months. Longterm over the coming years we can also see prices above 100$. The only reasonable place to put a stop right now is below 50$. So do your own diligence and research, this is just my opinion towards this stock. Fundamental analysis by Morgan Stanley: Veeva Systems Inc VEEV, a cloud-computing company focused on the pharma and life sciences industry, is an underpriced asset within the broader SaaS universe, according to Morgan Stanley. The Analyst Morgan Stanley analyst Stan Zlotsky upgraded Veeva Systems from Equal-weight to Overweight and increased the price target from $69 to $72. The Thesis Veeva Systems has durable growth — fueled by an expanding $17-billion total addressable market — and margin potential that is not being reflected in current trading levels, Zlotsky said in a Tuesday note. A conservative setup into 2019 offers scope for estimates and shares to move up, he said. The company's best-in-class economics are likely to drive longer-term operating margin to 43 percent, representing the highest margin potential in Morgan Stanley's coverage universe, Zlotsky said. "Veeva's above average sales efficiency and a disciplined go-to-market has enabled the company to simultaneously deliver strong revenue growth and greater than 30-percent operating margins today, well above the 18-percent average among more mature SaaS peers," the analyst said. Morgan Stanley estimates 16-percent revenue growth on a CAGR basis to $1.7 billion and a 36-percent operating margin by calendar year 2023, resulting in free cash flow of $593 million. With the 12-percent pullback in Veeva Systems shares since June 2017 compared to a 14-percent gain for the SaaS peer group, Morgan Stanley sees an attractive entry point to rebuild positions in the shares.
NYSE:VEEVLong
by IamJeanPaul
2